Lode, H N <br/><br/>
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.  [electronic resource] 

 -  The Journal of clinical investigation  Jun 2000 
 - 1623-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI9177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigen-Presenting Cells--physiology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD40 Antigens--genetics<br/>CD40 Ligand<br/>Female<br/>Interleukin-2--therapeutic use<br/>Lymphocyte Activation<br/>Melanoma, Experimental--immunology<br/>Membrane Glycoproteins--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout